AD |
Alzheimer’s Disease |
GAL |
Galantamine |
LYC |
Lycorine |
Aβ |
Amyloid-β |
AChE |
Acetylcholinesterase |
ROS |
Reactive Oxygen Species |
FDA |
Food and Drug Administration |
EMA |
European Medicines Agency |
BGM |
Basic Growth Medium |
DM |
Differentiation Medium |
ECM |
Extracellular Matrix |
EMEM |
Eagle’s Minimum Essential Medium |
BDNF |
Brain-Derived Neurotrophic Factor |
db-cAMP |
Dibutyryl cyclic AMP |
RA |
Retinoic Acid |
TMSP-d4 |
3-(Trimethylsilyl)-2,2,3,3-tetradeuteropropionic Acid Sodium Salt |
NOESY |
Nuclear Overhauser Enhancement Spectroscopy |
PCA |
Principal Component Analysis |
PLS-DA |
Partial Least Squares Discriminant Analysis |
Ortho-PLS-DA |
Orthogonal Partial Least Squares Discriminant Analysis |
ANOVA |
Analysis of Variance |
PC |
Principal Component |
TCA |
Tricarboxylic Acid |
CSF |
Cerebrospinal Fluid |
MIC |
Mild Cognitive Impairment |
PDHC |
Pyruvate-Dehydrogenase Complex |
α-KGDHC |
α-ketoglutarate Dehydrogenase |
CNS |
Central Nervous System |
EPO |
Erythropoietin |